BERETTA, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 14.231
AS - Asia 10.841
EU - Europa 6.371
SA - Sud America 1.413
Continente sconosciuto - Info sul continente non disponibili 741
AF - Africa 219
OC - Oceania 9
Totale 33.825
Nazione #
US - Stati Uniti d'America 13.428
SG - Singapore 3.760
VN - Vietnam 2.430
CN - Cina 1.876
IT - Italia 1.794
HK - Hong Kong 1.178
BR - Brasile 1.075
RU - Federazione Russa 1.038
DE - Germania 801
SE - Svezia 664
CA - Canada 631
IE - Irlanda 413
GB - Regno Unito 375
BD - Bangladesh 367
UA - Ucraina 291
FR - Francia 276
IN - India 263
FI - Finlandia 176
KR - Corea 152
AR - Argentina 129
TR - Turchia 129
ID - Indonesia 108
ES - Italia 96
IQ - Iraq 92
NL - Olanda 92
MX - Messico 89
AT - Austria 85
JP - Giappone 75
ZA - Sudafrica 67
PL - Polonia 57
CO - Colombia 53
PK - Pakistan 49
VE - Venezuela 46
PH - Filippine 44
SA - Arabia Saudita 43
EC - Ecuador 42
UZ - Uzbekistan 42
BE - Belgio 37
DK - Danimarca 31
EG - Egitto 31
LT - Lituania 28
MY - Malesia 25
CH - Svizzera 23
MA - Marocco 23
CZ - Repubblica Ceca 22
CL - Cile 21
KE - Kenya 21
TH - Thailandia 21
IR - Iran 19
CR - Costa Rica 17
AE - Emirati Arabi Uniti 16
JO - Giordania 16
PY - Paraguay 16
NP - Nepal 14
TN - Tunisia 14
JM - Giamaica 13
PE - Perù 13
AZ - Azerbaigian 12
ET - Etiopia 12
OM - Oman 12
UY - Uruguay 12
DZ - Algeria 11
IL - Israele 11
KG - Kirghizistan 11
LB - Libano 11
DO - Repubblica Dominicana 10
SN - Senegal 10
GR - Grecia 8
GT - Guatemala 8
HU - Ungheria 8
MN - Mongolia 8
AL - Albania 7
BG - Bulgaria 7
HN - Honduras 7
PS - Palestinian Territory 7
AU - Australia 6
EU - Europa 6
GE - Georgia 6
KZ - Kazakistan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BO - Bolivia 5
NI - Nicaragua 5
PA - Panama 5
RO - Romania 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
CI - Costa d'Avorio 4
EE - Estonia 4
HR - Croazia 4
KH - Cambogia 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
MD - Moldavia 4
PR - Porto Rico 4
TG - Togo 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BY - Bielorussia 3
Totale 33.031
Città #
Singapore 1.844
Ashburn 1.477
Ann Arbor 1.382
Hong Kong 1.137
San Jose 971
Hanoi 693
Ho Chi Minh City 680
Chandler 644
Woodbridge 637
Milan 564
Fairfield 517
Houston 516
Frankfurt am Main 455
Toronto 440
Dublin 402
Santa Clara 398
Los Angeles 392
Dallas 379
New York 375
Jacksonville 306
Wilmington 281
Hefei 271
Seattle 252
Beijing 249
Chicago 229
The Dalles 223
Dearborn 216
Cambridge 202
Council Bluffs 194
Princeton 177
Rome 149
Seoul 143
Boardman 136
Buffalo 134
Hangzhou 123
Lauterbourg 122
Shanghai 117
Columbus 114
São Paulo 109
Da Nang 102
Moscow 85
Orem 79
Nanjing 78
Helsinki 76
Altamura 74
Jakarta 73
Munich 70
Lawrence 68
Haiphong 65
Nuremberg 62
Tokyo 61
Montreal 60
Denver 54
San Diego 53
Guangzhou 52
London 52
Dong Ket 51
Lachine 51
Brooklyn 45
Vienna 45
Warsaw 45
Hải Dương 44
Biên Hòa 43
Atlanta 41
Baghdad 41
Phoenix 38
Quận Bình Thạnh 37
Mountain View 36
San Francisco 36
Tashkent 36
Brussels 35
Can Tho 35
Rio de Janeiro 35
Shenyang 35
Poplar 34
Thái Nguyên 34
Quận Một 33
Dhaka 32
Turin 32
Manchester 31
Johannesburg 30
Nanchang 30
Fremont 29
Mexico City 29
Stockholm 29
Figino 28
Hebei 27
Vũng Tàu 27
Andover 26
Boston 26
Turku 26
Amsterdam 25
Ninh Bình 25
Salt Lake City 25
Istanbul 24
Bắc Giang 23
Changsha 22
Ha Long 22
Madrid 22
Naples 22
Totale 20.256
Nome #
Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke 1.108
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 576
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 555
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 487
The role of clinical and neuroimaging features in the diagnosis of CADASIL 443
Prognostic Value of Signal Abnormalities on Brain MRI in Post-Anoxic Super-Refractory Status Epilepticus: A Single-Center Retrospective Study 432
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 410
Guillain-Barré syndrome related to COVID-19 infection 401
Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network 395
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 393
Implementation of continuous qEEG in two neurointensive care units by intensivists: a feasibility study 384
Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment 382
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 370
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 367
Incidence and predictors of acute symptomatic seizures after stroke 366
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 364
Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 Infection 363
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 361
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 359
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 359
Intracranial collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 345
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 326
Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease 324
Intracranial Collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 324
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 319
Neurological outcome of postanoxic refractory status epilepticus after aggressive treatment 315
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 314
Topographical and morphological patterns of post reperfusion molecular penumbra 313
Prognostic patterns and predictors in epilepsy: A multicentre study (PRO-LONG) 308
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 306
Impact of COVID-19 on functional, cognitive, neuropsychiatric, and health-related outcomes in patients with dementia: A systematic review 306
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 304
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 301
Therapeutic modulation of intracranial collateral flow improves outcome in experimental ischemic stroke 301
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 301
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 298
Guillain–Barré Syndrome Associated with COVID-19 295
SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy 295
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 294
Absence and reappearance of N20 response after thiopental withdrawal in postanoxic coma 292
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study 287
Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection 286
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 283
Clinical factors associated with statins prescription in acute ischemic stroke patients: Findings from the Lombardia Stroke Registry 276
A multidisciplinary approach to screen the post-COVID-19 conditions 273
Intracranial collateral flow in experimental ischemic stroke. From hemodynamic monitoring to collateral therapeutics 273
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 272
Thermal plantar test in experimental ischemic stroke 271
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 269
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 268
Experimental in-vivo model of intravascular shunting for neurosurgical bypass 268
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 266
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 263
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 259
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 259
Cerebral collateral circulation in experimental ischemic stroke 258
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 257
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 257
Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series 255
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: The ICARO-2 study 252
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 245
The THRombolysis and STatins (THRaST) study 245
Chapter 16. Impact of COVID-19 on pre-existing neurological diseases 245
Optimized system for cerebral perfusion monitoring in the rat stroke model of intraluminal middle cerebral artery occlusion 239
Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network 236
Enhanced recovery strategies in colorectal surgery: is the compliance with the whole program required to achieve the target? 235
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW) 229
Double antiglutamatergic therapy in a case of postanoxic super-refractory status epilepticus 228
Guillain-Barré syndrome AMSAN variant in a 90-year-old woman after COVID-19: a case report 227
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 220
Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: A pilot study 220
From observation to monitoring: implementation of quantitative electroencephalography (QEEG) in neurointensive care 220
Discontinuation of antiseizure medications in seizure-free patients with long-term follow-up: Patients’ profile, seizure recurrence, and risk factors 219
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 218
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 217
Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol 215
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) 214
Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): A pragmatic randomised trial 214
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 203
Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients 203
Pharmacological manipulation of glutamate transport 202
Head-down tilt 15° increases cerebral perfusion before recanalization in acute ischemic stroke. A pre-clinical MRI study 200
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 197
Peripheral markers of glutamatergic dysfunction in neurological disease: focus on ex vivo tools 197
Brain ultrasound rehearsal before surgery: A pilot cadaver study 196
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 192
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 192
Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults 187
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 186
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 186
Head down positioning before recanalization in acute ischemic stroke 186
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 185
Elevated peripheral leukocyte counts in acute cervical artery dissection 185
Spectral properties of the EEG during recovery of consciousness after acute brain injury 182
Possible neuroprotective strategies in ALS 180
Quantitative EEG interpretation by EEG-naïve neurointensivists before and after expert training 179
Pathogenesis of retinal ganglion cell death in Leber hereditary optic neuropathy (LHON): possible involvement of mitochondria, light and glutamate 178
Thrombolysis in Cervical Artery Dissection - Data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database 176
Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke 175
COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy) 175
Totale 28.636
Categoria #
all - tutte 105.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.077


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.249 0 137 155 87 106 98 52 54 77 111 146 226
2022/20232.259 257 710 202 224 118 328 24 138 132 10 64 52
2023/20241.818 46 38 95 115 198 393 362 52 176 18 63 262
2024/20256.822 266 487 239 203 440 266 348 201 533 840 846 2.153
2025/202614.240 1.750 956 1.047 1.392 1.639 684 1.995 583 971 1.241 876 1.106
2026/20271.208 545 663 0 0 0 0 0 0 0 0 0 0
Totale 33.825